eGFRcys resulted in smallest change in CKD prevalence among Black adults compared with race-blended, race-removed equations
FRIDAY, July 30, 2021 (HealthDay News) — The chronic kidney disease (CKD) Epidemiology Consortium estimated glomerular filtration rate cystatin C (eGFRcys), the only guideline-recommended equation that does not require race, results in the smallest changes to eGFR among Black patients, according to a research letter published online July 29 in the Journal of the American Society of Nephrology.
James A. Diao, from Boston Children’s Hospital, and colleagues compared eGFR distributions for race-free eGFR equations and equations using serum creatinine and requiring race (eGFRcr and eGFRcr-cys [computed from creatinine and cystatin C, respectively]). The distributions of eGFR were compared using data from the National Health and Nutrition Examination Survey, for a sample of 4,434 nonpregnant adults from 1999 to 2002.
The researchers found that eGFRcys resulted in the smallest change in CKD prevalence among Black adults relative to eGFRcr-cys (0.7 percent) compared to race-blended or race-removed equations (1.4 to 4.5 percent). The smallest median change in eGFR in Black adults was seen with eGFRcys (−0.8 mL/min/1.73 m2) compared with other race-free alternatives, which varied from 11.3 to 29.0 for race-blended and race-removed models, respectively. The smallest gap in CKD prevalence between Black and White/other patients was seen with eGFRcys (3.7 percent) relative to other race-free equations (6.1 to 7.4 percent).
“Our findings indicate that race-free alternatives may vary considerably in effects on chronic kidney disease classification,” a coauthor said in a statement. “We hope these estimates will be useful to the many individuals and groups working to improve kidney function estimation without race.”
Abstract/Full Text (subscription or payment may be required)
UACR, UPCR Provide Indistinguishable Prognostic Information in CKD
MHT Initiation May Reduce Cardiovascular Risk in Women With Vasomotor Symptoms
Retinal Imaging Can ID Atrial Fibrillation Years Before Diagnosis
Recommendations Updated for Management of Anemia in CKD
Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL
More Advanced CKM Syndrome Linked to Worse Cardiovascular Health
Preoperative IV Iron Beneficial for Patients With Anemia Undergoing Cardiac Surgery